Vyome Holdings, Inc. (HIND)
2.06
-0.04
(-1.90%)
USD |
NASDAQ |
Sep 11, 16:00
2.10
+0.04
(+1.94%)
Pre-Market: 20:00
Vyome Holdings Price : 2.06 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 2.11 | 2.11 | 2.05 | 2.06 | 17529.00 |
| Sep 10, 2026 | 2.05 | 2.10 | 2.05 | 2.10 | 3199.00 |
| Sep 09, 2026 | 2.06 | 2.060 | 2.06 | 2.06 | 3988.00 |
| Sep 08, 2026 | 2.23 | 2.23 | 2.06 | 2.09 | 19171.00 |
| Sep 04, 2026 | 2.133 | 2.229 | 2.133 | 2.22 | 2307.00 |
| Sep 03, 2026 | 2.20 | 2.270 | 2.20 | 2.23 | 14443.00 |
| Sep 02, 2026 | 2.13 | 2.18 | 2.13 | 2.18 | 4404.00 |
| Sep 01, 2026 | 2.15 | 2.17 | 2.13 | 2.17 | 5938.00 |
| Aug 31, 2026 | 2.16 | 2.23 | 2.151 | 2.160 | 7176.00 |
| Aug 28, 2026 | 2.265 | 2.265 | 2.205 | 2.205 | 2289.00 |
| Aug 27, 2026 | 2.21 | 2.23 | 2.170 | 2.21 | 2223.00 |
| Aug 26, 2026 | 2.28 | 2.28 | 2.150 | 2.16 | 11792.00 |
| Aug 25, 2026 | 2.279 | 2.279 | 2.23 | 2.23 | 1623.00 |
| Aug 24, 2026 | 2.19 | 2.300 | 2.19 | 2.242 | 3668.00 |
| Aug 21, 2026 | 2.21 | 2.30 | 2.21 | 2.25 | 4688.00 |
| Aug 20, 2026 | 2.28 | 2.32 | 2.225 | 2.28 | 9489.00 |
| Aug 19, 2026 | 2.199 | 2.359 | 2.199 | 2.32 | 25397.00 |
| Aug 18, 2026 | 2.224 | 2.27 | 2.139 | 2.270 | 6660.00 |
| Aug 17, 2026 | 2.13 | 2.30 | 2.13 | 2.27 | 14413.00 |
| Aug 14, 2026 | 2.17 | 2.23 | 2.12 | 2.18 | 6140.00 |
| Aug 13, 2026 | 2.18 | 2.24 | 2.13 | 2.16 | 5410.00 |
| Aug 12, 2026 | 2.26 | 2.26 | 2.22 | 2.22 | 11494.00 |
| Aug 11, 2026 | 2.236 | 2.274 | 2.230 | 2.25 | 9078.00 |
| Aug 10, 2026 | 2.16 | 2.22 | 2.130 | 2.21 | 6265.00 |
| Aug 07, 2026 | 2.10 | 2.16 | 1.99 | 2.16 | 15216.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cardiac Biotech Solutions, Inc. | 0.0355 |
| Anika Therapeutics, Inc. | 20.86 |
| Enovis Corp. | 19.28 |
| Edwards Lifesciences Corp. | 84.37 |
| Perspective Therapeutics, Inc. | 2.81 |
Price Related Metrics
| PS Ratio | 88.89 |
| Price to Book Value | 2.390 |
| Price to Free Cash Flow | 21.98 |
| Earnings Yield | -170.2% |
| Market Cap | 14.46M |